Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Reiterates Overweight on Synopsys, Raises Price Target to $672

Author: Benzinga Newsdesk | May 23, 2024 05:10am
Piper Sandler analyst Clarke Jeffries reiterates Synopsys (NASDAQ:SNPS) with a Overweight and raises the price target from $665 to $672.

Posted In: SNPS